Development of a skin benign tumor, cancer and melanoma from the view point of morphofunctional zones

  • Yavisheva T. M. Head of scientific laboratory of mechanisms of stem cells regulation, Stock company “R-Pharm”, Russian Federation
  • Shcherbakov S.D. Professor of scientific laboratory of mechanisms of stem cells regulation, Stock company “R-Pharm”, Russian Federation
Keywords: morphofunctional zones, stem cells quantity, skin benign tumor, cancer, melanoma

Abstract

Development  of a benign and malignant skin tumor in a morphofunctional zone in many respects depends on the quantity of cambial cells, which excite  an electric field at their division, due to  which  the inactive Src-kinase, participating in a formation of the cytoskeleton  and a differentiation,  is  expressed in cells. Decrease in cells number  to 8 leads to formation of a benign tumor, and up to 6 – to malignant as this quantity of cambial cells can't express enough inactive Src-kinase, necessary for  a normal cytoskeleton formation. The skin melanoma  can develop  without decrease in  cambial cells number due to sharp redistribution between shares of inactive and the active Src-kinase, thus the cytoskeleton formation and cell differentiation fall.

References

1. Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi Y. and Yazaki,Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. Journal of Clinical Investigation. 1997.100(7):1813-1821.
2. Burova, EB., Gonchar, IV. and Nikolsky, NN. Stat1 and stat3 activation by oxidative stress in A431 cells involves src-dependent EGF receptor tranactivation. Tsitologiya. 2003.45(5):466-477.
3. Devary, Y., Gottlieb, RA., Smeal T. and Karin, M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell. 1992.71(7):1081-1091.
4.Yagubov A.S. Danilenko V. I. Bogush I.G. Astemirova L.T. Stereomicroscopy in determination of symmetry of development of non-tumor processes and a cancer. Articles collection, devoted to the 80 anniversary of G.G. Avtandilov. Diagnostic medical morphometry. M, 2002. P. 137-142.
5. Yavisheva T.M. Shcherbakov S.D. Epithelial-stromal morphofunctional zones: structure and functions. Moscow, 2013.
6. Yavisheva T.M. Shcherbakov S. D.Development of melanoma and cancer without decreasing of cambial cells number in morphofunctional zones. Advances in Bioscience and Biotechnology. 2014.5:493-500.
7.Yavisheva, TM. and Shcherbakov, SD . Participation of an inactive and active Src-kinase in formation of a cytoskeleton and melanogenesis in Hep2 cells. International Journal of Current Microbiology and Applied Sciences. 2016.5(12):583-593
8. Yavisheva T.M. Shcherbakov, S.D., Golubeva I.S. Sharafutdinov G. Z. Savluchinskaya L.A. To a question of the structural organization of the basal layer and morphofunctional features of mouse epidermis cambial cells. Byulleten Eksperimentalnoi Biologii I Meditsiny 2004. 5: P. 584-588.
9. Yavisheva T.M. Shcherbakov S. D., Savluchinskaya L.A. Features of morphofunctional zones work in the normal epithelium, breast fibroadenoma and breast cancer. Dokl. AN . 2005 . 404(1): 125-128.
10.Yavisheva TM, Shcherbakov SD, Golubeva IS, Sharafutdinov GZ Interaction of cambial dermal cells (fibroblasts) and epidermis in morphofunctional area of mouse skin Byulleten Eksperimentalnoi Biologii I Meditsiny 2007 144 (5):748-753.
11.Yavisheva, TM., Shcherbakov, SD, Golubeva, IS Some aspects of morphofunctional organization of germinal regions of the hippocampus and olfactory bulb in young and old mice International journal of innovative studies in medical sciences 2017 l.(1):1-8.
Published
2018-12-30
How to Cite
T. M., Y., & S.D., S. (2018). Development of a skin benign tumor, cancer and melanoma from the view point of morphofunctional zones. International Journal For Research In Health Sciences And Nursing (ISSN: 2208-2670), 4(12), 01-05. Retrieved from https://gnpublication.org/index.php/hsn/article/view/798